Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Background: Chronic kidney disease (CKD) is a public health problem largely caused by diabetes. The epidemiology of diabetes mellitus–related CKD (CKD-DM) could provide specific support to lessen global, regional, and national CKD burden. Methods: Data were derived from the GBD 2019 study, including four measures and age-standardized rates (ASRs). Estimated annual percentage changes and 95% CIs were calculated to evaluate the variation trend of ASRs. Results: Diabetes caused the majority of new cases and patients with CKD in all regions. All ASRs for type 2 diabetes–related CKD increased over 30 years. Asia and Middle socio-demographic index (SDI) quintile always carried the heaviest burden of CKD-DM. Diabetes type 2 became the second leading cause of CKD and CKD-related death and the third leading cause of CKD-related DALYs in 2019. Type 2 diabetes–related CKD accounted for most of the CKD-DM disease burden. There were 2.62 million incident cases, 134.58 million patients, 405.99 thousand deaths, and 13.09 million disability-adjusted life-years (DALYs) of CKD-DM worldwide in 2019. Age-standardized incidence (ASIR) and prevalence rate (ASPR) of type 1 diabetes–related CKD increased, whereas age-standardized death rate (ASDR) and DALY rate decreased for females and increased for males. In high SDI quintile, ASIR and ASPR of type 1 diabetes–related CKD remained the highest, with the slowest increase, whereas the ASDR and age-standardized DALY rate remained the lowest there. In high SDI quintile, ASIR of type 2 diabetes–related CKD was the highest, with the lowest increasing rate. In addition, type 2 diabetes–related CKD occurred most in people aged 80-plus years worldwide. The main age of type 2 diabetes–related CKD patients was 55–64 years in Asia and Africa. The prevalence, mortality, and DALY rate of type 2 diabetes–related CKD increased with age. As for incidence, there was a peak at 80 years, and after age of 80, the incidence declined. CKD-DM-related anemia was mainly in mild to moderate grade. Conclusions: Increasing burden of CKD-DM varied among regions and countries. Prevention and treatment measures should be strengthened according to CKD-DM epidemiology, especially in middle SDI quintile and Asia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Self-citationVos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30045-3 · Cited by 6,648
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J., Balkrishnan, R., Bragg-Gresham, J., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,191
Self-citationA systematic analysis of global anemia burden from 1990 to 2010
Kassebaum, N. J., Jasrasaria, R., Naghavi, M., Wulf, S. K., Johns, N., Lozano, R., Regan, M., Weatherall, D., Chou, D. P., Eisele, T. P., et al. (2014) · Blood · doi:10.1182/blood-2013-06-508325 · Cited by 2,075
The Global Epidemiology of Diabetes and Kidney Disease
Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.10.011 · Cited by 686 · cited 2×
“Diabetic nephropathy, the leading cause of end-stage renal disease (ESRD), is associated with the excess mortality in diabetic patients (8, 9).”
BackgroundThe presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
The global burden of chronic kidney disease: estimates, variability and pitfalls
Glassock, R. J., Warnock, D. G., & Delanaye, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.163 · Cited by 511
Golden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2043 · Cited by 405
Lanting, L. C., Joung, I. M. A., Mackenbach, J. P., Lamberts, S. W. J., & Bootsma, A. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2280 · Cited by 386
Global Burden of Thyroid Cancer From 1990 to 2017
Deng, Y., Li, H., Wang, M., Li, N., Tian, T., Wu, Y., Xu, P., Yang, S., Zhai, Z., Zhou, L., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8759 · Cited by 348
Self-citationLiu, J., Ren, Z.-H., Qiang, H., Wu, J., Shen, M., Zhang, L., & Lyu, J. (2020) · BMC Public Health · doi:10.1186/s12889-020-09502-x · Cited by 313
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update
Roumeliotis, S., Mallamaci, F., & Zoccali, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082359 · Cited by 284
Deng, Y., Zhao, P., Zhou, L., Xiang, D., Hu, J., Liu, Y., Ruan, J., Ye, X., Zheng, Y., Yao, J., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00915-0 · Cited by 259
Self-citationVadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD
Chertow, G. M., Pergola, P. E., Farag, Y. M. K., Agarwal, R., Arnold, S., Bako, G., Block, G. A., Burke, S., Castillo, F. P., Jardine, A. G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035938 · Cited by 254
Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis
Kaze, A. D., Ilori, T., Jaar, B. G., & Echouffo-Tcheugui, J. B. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0930-5 · Cited by 249
Early detection of kidney disease in community settings: the kidney early evaluation program (KEEP)
Brown, W. W., Peters, R. M., Ohmit, S. E., Keane, W. F., Collins, A., Chen, S.-C., King, K., Klag, M. J., Molony, D. A., & Flack, J. M. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00405-0 · Cited by 243
The ascending rank of chronic kidney disease in the global burden of disease study
Jager, K. J., & Fraser, S. D. S. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw330 · Cited by 196
Bowe, B., Xie, Y., Li, T., Mokdad, A. H., Xian, H., Yan, Y., Maddukuri, G., & Al-Aly, Z. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.4412 · Cited by 168
Wilson, S. M., Mone, P., Jankauskas, S. S., Gambardella, J., & Santulli, G. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14186 · Cited by 156
Sex differences in diabetes and kidney disease: mechanisms and consequences
Shepard, B. D. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00249.2019 · Cited by 135
Epidemiology of Type 1 and Type 2 Diabetes in Africa
Motala, A. A., Omar, M. A. K., & Pirie, F. J. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670301000202 · Cited by 102
Diabetes in Africa. Epidemiology of type 1 and type 2 diabetes in Africa.
Motala, A. A., Omar, M. A. K., & Pirie, F. J. (2003) · PubMed · doi:10.1097/01.hjr.0000060843.48106.31 · Cited by 96
Kidney disease in the Global Burden of Disease Study 2017
Fraser, S. D., & Roderick, P. J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0120-0 · Cited by 90
Racial Disparities in Diabetes Mortality in the 50 Most Populous US Cities
Rosenstock, S., Whitman, S., West, J. F., & Balkin, M. (2014) · Journal of Urban Health · doi:10.1007/s11524-013-9861-4 · Cited by 83
Wirth, J. P., Rohner, F., Woodruff, B. A., Chiwile, F., Yankson, H., Koroma, A. S., Russel, F., Sesay, F. F., Dominguez, E., Petry, N., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155031 · Cited by 82
Disparities in diabetes-related multiple chronic conditions and mortality: The influence of race
Clements, J. M., West, B. T., Yaker, Z. S., Lauinger, B., Deven, M., Haubert, J., Tahboub, M. A., & Everett, G. J. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107984 · Cited by 74
Bjornstad, P., & Cherney, D. Z. I. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0996-2 · Cited by 57
Hansson, E., Mansourian, A., Farnaghi, M., Petzold, M., & Jakobsson, K. (2021) · BMC Public Health · doi:10.1186/s12889-021-10822-9 · Cited by 45
Pacilli, A., Viazzi, F. C., Fioretto, P., Giorda, C. B., Ceriello, A., Genovese, S., Russo, G. T., Guida, P., Pontremoli, R., Cosmo, S. D., et al. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2873 · Cited by 44
Carga, acceso y disparidades en enfermedad renal
Crews, D. C., Bello, A. K., & Saadi, G. (2019) · Revista Colombiana de Nefrología · doi:10.22265/acnef.6.1.341 · Cited by 43
Diabetic kidney disease in A ustralia: Current burden and future projections
White, S., & Chadban, S. J. (2014) · Nephrology · doi:10.1111/nep.12281 · Cited by 40
Hu, Y., Lei, M., Ke, G., Huang, X., Peng, X., Zhong, L., & Fu, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.559446 · Cited by 39
Insaf, T. Z., Strogatz, D. S., Yucel, R. M., Chasan‐Taber, L., & Shaw, B. A. (2013) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2013-202585 · Cited by 34
Surveillance of CKD epidemiology in the US – a joint analysis of NHANES and KEEP
Myers, O., Pankratz, V. S., Norris, K. C., Vassalotti, J. A., Unruh, M. L., & Argyropoulos, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34233-w · Cited by 31
Rami-Merhar, B. M., Hofer, S. E., Fröhlich-Reiterer, E. E., Waldhoer, T., Fritsch, M., & for the Austrian Diabetes Incidence Study Group (2020) · Pediatric Diabetes · doi:10.1111/pedi.13038 · Cited by 27
Advances in the management of diabetes: new devices for type 1 diabetes
Wunna, W., Tsoutsouki, J., Chowdhury, A., & Chowdhury, T. A. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138016 · Cited by 25
Horlyck-Romanovsky, M., Wyka, K., Echeverría, S. E., Leung, M. M., Fuster, M., & Huang, T. T. ‐. (2018) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-018-0708-7 · Cited by 22
Burden, access, and disparities in kidney disease
Crews, D. C., Bello, A. K., & Saadi, G. E. (2019) · Journal of Nephrology · doi:10.1007/s40620-019-00590-6 · Cited by 21
Rahmani, H., Asiabar, A. S., Niakan, S., Hashemi, S. Y., Faramarzi, A., Manuchehri, S., & Vasokolaei, G. R. (2018) · Medical Journal of the Islamic Republic of Iran · doi:10.14196/mjiri.32.55 · Cited by 19
Kidney failure risk in type 1 vs. type 2 childhood-onset diabetes mellitus
Pleniceanu, O., Twig, G., Tzur, D., Gruber, N., Stern-Zimmer, M., Afek, A. B., Erlich, T., Keinan‐Boker, L., Skorecki, K. L., Calderon‐Margalit, R., et al. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04631-2 · Cited by 14
Nahvijou, A., Arab, M., Faramarzi, A., Hashemi, S. Y., & Javan‐Noughabi, J. (2019) · Health Scope · doi:10.5812/jhealthscope.64984 · Cited by 7
Cited by
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Chen, J., Liu, Q., He, J., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958790 · Cited by 164
Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes
Chuang, M.-H., Chen, J.-Y., Wang, H.-Y., Jiang, Z.-H., & Wu, V.-C. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.27258 · Cited by 133
Betzler, B. K., Chee, E. Y. L., He, F., Lim, C. C., Ho, J., Hamzah, H., Tan, N. C., Liew, G., McKay, G. J., Hogg, R. E., et al. (2023) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad179 · Cited by 42
Abegaz, T. M., Diaby, V., Sherbeny, F., & Ali, A. A. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-022-01160-8 · Cited by 15
Metadata
- Authors
- Deng, Y., Li, N., Wu, Y., Wang, M., Yang, S., Zheng, Y., Deng, X., Xiang, D., Zhu, Y., Xu, P., Zhai, Z., Zhang, D., Dai, Z., & Gao, J.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2021-07-01
- Volume
- 12
- Pages
- 672350-672350
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W3185976379
- Cited by
- 319
- References
- 45
- FWCI
- 28.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.